Valeant Pharmaceuticals International has raised C$750m ($591.37m) through the private placement of senior secured notes.
Due 2025, the notes carry a rate of 5.5%.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The US-based pharmaceutical company plans to use the funds to repay a part of its outstanding loan and for related expenses.
UK-based pharmaceutical products manufacturer Hikma Pharmaceuticals has acquired six products from German pharmaceutical company Boehringer Ingelheim for €3m ($3.49m).
The products acquired include Alupent, Gastrozepin, Paracefan, Partusisten and Spiropent in Germany and Mantadan in Italy.
Chinese pharmaceutical company Yabao Pharmaceutical Group plans to raise CNY500m ($75.29m) through the private placement of corporate bonds.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSynergy Pharmaceuticals has announced a public offering of 21 million shares of its common stock priced at $2.58 a share to raise $56m.
The US-based biopharmaceutical company plans to use the funds towards general corporate purposes, working capital, and capital expenditures.
